首页|2018-2022年成都地区医院感染现患率调查

2018-2022年成都地区医院感染现患率调查

扫码查看
目的 对2018-2022年成都地区医疗机构现患率、感染科室、抗菌药物使用情况等进行分析,为各级医疗机构横向对比、采取医院感染防控措施提供数据支撑和依据.方法 采用横断面调查方法对成都地区2018-2022年医疗机构所有住院患者进行调查,对调查结果进行比较分析.结果 2018-2022年成都地区医院感染率分别为1.69%、1.55%、1.68%、1.51%和1.52%,差异有统计学意义(P=0.021),呈逐年下降趋势(x2=4.660,P=0.031);2018-2022年不同规模医疗机构现患率总体差异有统计学意义(P<0.001);随着医疗机构规模增大现患率呈增加趋势(趋势卡方P<0.001);2018-2022年成都地区现患率最高的科室为综合重症监护室(ICU),分别为20.27%、21.43%、14.08%、18.68%和15.59%;感染部位以下呼吸道感染占比最高,依次占57.30%、55.50%、56.89%、55.58%和58.29%;除2018年外其余年份均呈现医疗机构规模越大抗菌药物使用率越低(P<0.05);2018-2022年成都地区抗菌药物使用呈明显下降趋势(P<0.001),大肠埃希菌对头孢他啶耐药率呈上升趋势(P=0.023).结论 近5年成都地区医院感染现患率及抗菌药物使用率呈下降趋势,但重点病原菌对部分药物耐药率呈上升趋势.
Investigation the prevalence rates of nosocomial infections in Chengdu area from 2018 to 2022
OBJECTIVE To analyze the prevalence rate,infection departments,and antibacterial drug use in Cheng-du area from 2018 to 2022,and to provide data support for horizontal comparison and implementing nosocomial infection prevention and control measures by medical institutions.METHODS A cross-sectional survey was conduc-ted on all inpatient in Chengdu area from 2018 to 2022.RESULTS The nosocomial infection rates in Chengdu were 1.69%,1.55%,1.68%,1.51%,and 1.52%,respectively,with statistically significant differences(P=0.021),and showed a decreasing trend year by year(x2=4.660,P=0.031).The prevalence rate was significant difference(P<0.001)among medical institutions of different scales from 2018 to 2022(P<0.001).The inci-dence rate increased with the increase of the scale of medical institutions(chi-square for trend P<0.001).The in-cidence rates of comprehensive intensive care unit(ICU)in Chengdu from 2018 to 2022 were the highest,which was 20.27%,21.43%,14.08%,18.68%,and 15.59%,respectively.Lower respiratory tract infection accoun-ted for the highest proportion,accounting for 57.30%,55.50%,56.89%,55.58%and 58.29%respectively.Except for 2018,the medical institutions with the larger scale had the lower the usage rate of antibiotics(P<0.05).The use of antibiotics in Chengdu aera showed a significant decreasing trend from 2018 to 2022(P<0.001).The drug resistance rate of Escherichia coli to ceftazidime increased(P=0.023).CONCLUSION In the past five years,the prevalence rate and the use of antibiotics in Chengdu showed a decreasing trend,but the drug resistance rate of pathogens to certain antibiotics increased.

Nosocomial infectionPrevalence rateInvestigationAntimicrobial agentTrend analysisChengdu

裴小琴、郭华、吕宇、向钱、罗淇、梁子超

展开 >

成都市第三人民医院医院感染管理部,四川成都 610031

四川省医学科学院·四川省人民医院医院感染管理中心,四川成都 610072

医院感染 现患率 调查 抗菌药物 趋势分析 成都

四川省自然科学基金面上项目

2023NSFSC0534

2024

中华医院感染学杂志
中华预防医学会 中国人民解放军总医院

中华医院感染学杂志

CSTPCD北大核心
影响因子:1.885
ISSN:1005-4529
年,卷(期):2024.34(15)
  • 1
  • 7